1
|
Westphal M and Lamszus K: The neurobiology
of gliomas: from cell biology to the development of therapeutic
approaches. Nat Rev Neurosci. 12:495–508. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Hatanpaa KJ, Burma S, Zhao D and Habib AA:
Epidermal growth factor receptor in glioma: signal transduction,
neuropathology, imaging, and radioresistance. Neoplasia.
12:675–684. 2010.PubMed/NCBI
|
3
|
Yan H, Parsons DW, Jin G, McLendon R,
Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ,
et al: IDH1 and IDH2 mutations in gliomas. New Eng J Med.
360:765–773. 2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Endersby R and Baker SJ: PTEN signaling in
brain: neuropathology and tumorigenesis. Oncogene. 27:5416–5430.
2008. View Article : Google Scholar : PubMed/NCBI
|
5
|
Giannopoulos S and Kyritsis AP: Diagnosis
and management of multifocal gliomas. Oncology. 79:306–312. 2010.
View Article : Google Scholar
|
6
|
Wurdinger T, Tannous BA, Saydam O, Skog J,
Grau S, Soutschek J, Weissleder R, Breakefield XO and Krichevsky
AM: miR-296 regulates growth factor receptor overexpression in
angiogenic endothelial cells. Cancer Cell. 14:382–393. 2008.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Wu WK, Law PT, Lee CW, Cho CH, Fan D, Wu
K, Yu J and Sung JJ: MicroRNA in colorectal cancer: from benchtop
to bedside. Carcinogenesis. 32:247–253. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J
and Sung JJ: MicroRNA dysregulation in gastric cancer: a new player
enters the game. Oncogene. 29:5761–5771. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Baraniskin A, Kuhnhenn J, Schlegel U,
Maghnouj A, Zollner H, Schmiegel W, Hahn S and Schroers R:
Identification of microRNAs in the cerebrospinal fluid as biomarker
for the diagnosis of glioma. Neuro Oncol. 14:29–33. 2012.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Chan JA, Krichevsky AM and Kosik KS:
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI
|
11
|
Quintavalle C, Garofalo M, Zanca C, Romano
G, Iaboni M, Del Basso De Caro M, Martinez-Montero JC, Incoronato
M, Nuovo G, Croce CM and Condorelli G: miR-221/222 overexpession in
human glioblastoma increases invasiveness by targeting the protein
phosphate PTPmu. Oncogene. 31:858–868. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Kefas B, Godlewski J, Comeau L, Li Y,
Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S and
Purow B: microRNA-7 inhibits the epidermal growth factor receptor
and the Akt pathway and is down-regulated in glioblastoma. Cancer
Res. 68:3566–3572. 2008. View Article : Google Scholar : PubMed/NCBI
|
13
|
Li KK, Pang JC, Ching AK, Wong CK, Kong X,
Wang Y, Zhou L, Chen Z and Ng HK: miR-124 is frequently
down-regulated in medulloblastoma and is a negative regulator of
SLC16A1. Hum Pathol. 40:1234–1243. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Godlewski J, Nowicki MO, Bronisz A,
Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca
EA and Lawler S: Targeting of the Bmi-1 oncogene/stem cell renewal
factor by microRNA-128 inhibits glioma proliferation and
self-renewal. Cancer Res. 68:9125–9130. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Silber J, Lim DA, Petritsch C, Persson AI,
Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello
JF, et al: miR-124 and miR-137 inhibit proliferation of
glioblastoma multiforme cells and induce differentiation of brain
tumor stem cells. BMC Med. 6:142008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu
Z and You Y: hsa-mir-181a and hsa-mir-181b function as tumor
suppressors in human glioma cells. Brain Res. 1236:185–193. 2008.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Ciafre SA, Galardi S, Mangiola A, Ferracin
M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM and Farace MG:
Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun. 334:1351–1358. 2005. View Article : Google Scholar : PubMed/NCBI
|
18
|
Mertens-Talcott SU, Chintharlapalli S, Li
X and Safe S: The oncogenic microRNA-27a targets genes that
regulate specificity protein transcription factors and the G2-M
checkpoint in MDA-MB-231 breast cancer cells. Cancer Res.
67:11001–11011. 2007. View Article : Google Scholar
|
19
|
Liu T, Tang H, Lang Y, Liu M and Li X:
MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by
targeting prohibitin. Cancer Lett. 273:233–242. 2009. View Article : Google Scholar : PubMed/NCBI
|
20
|
Chintharlapalli S, Papineni S, Abdelrahim
M, Abudayyeh A, Jutooru I, Chadalapaka G, Wu F, Mertens-Talcott S,
Vanderlaag K, Cho SD, Smith R III and Safe S: Oncogenic
microRNA-27a is a target for anticancer agent methyl
2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer
cells. Int J Cancer. 125:1965–1974. 2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
Ma Y, Yu S, Zhao W, Lu Z and Chen J:
miR-27a regulates the growth, colony formation and migration of
pancreatic cancer cells by targeting Sprouty2. Cancer Lett.
298:150–158. 2010. View Article : Google Scholar : PubMed/NCBI
|
22
|
Skog J, Wurdinger T, van Rijn S, Meijer
DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky
AM and Breakefield XO: Glioblastoma microvesicles transport RNA and
proteins that promote tumour growth and provide diagnostic
biomarkers. Nat Cell Biol. 10:1470–1476. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Wang Q, Li DC, Li ZF, Liu CX, Xiao YM,
Zhang B, Li XD, Zhao J, Chen LP, Xing XM, et al: Upregulation of
miR-27a contributes to the malignant transformation of human
bronchial epithelial cells induced by SV40 small T antigen.
Oncogene. 30:3875–3886. 2011. View Article : Google Scholar : PubMed/NCBI
|
24
|
Katada T, Ishiguro H, Kuwabara Y, Kimura
M, Mitui A, Mori Y, Ogawa R, Harata K and Fujii Y: microRNA
expression profile in undifferentiated gastric cancer. Int J Oncol.
34:537–542. 2009.PubMed/NCBI
|
25
|
Zhu H, Wu H, Liu X, Evans BR, Medina DJ,
Liu CG and Yang JM: Role of MicroRNA miR-27a and miR-451 in the
regulation of MDR1/P-glycoprotein expression in human cancer cells.
Biochem Pharmacol. 76:582–588. 2008. View Article : Google Scholar : PubMed/NCBI
|
26
|
Chhabra R, Adlakha YK, Hariharan M, Scaria
V and Saini N: Upregulation of miR-23a-27a-24-2 cluster induces
caspase-dependent and -independent apoptosis in human embryonic
kidney cells. PloS One. 4:e58482009. View Article : Google Scholar : PubMed/NCBI
|
27
|
Li X, Mertens-Talcott SU, Zhang S, Kim K,
Ball J and Safe S: MicroRNA-27a indirectly regulates estrogen
receptor {alpha} expression and hormone responsiveness in MCF-7
breast cancer cells. Endocrinology. 151:2462–2473. 2010.PubMed/NCBI
|
28
|
Scott GK, Mattie MD, Berger CE, Benz SC
and Benz CC: Rapid alteration of microRNA levels by histone
deacetylase inhibition. Cancer Res. 66:1277–1281. 2006. View Article : Google Scholar : PubMed/NCBI
|
29
|
Guttilla IK and White BA: Coordinate
regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast
cancer cells. J Biol Chem. 284:23204–23216. 2009. View Article : Google Scholar : PubMed/NCBI
|
30
|
Li Z, Hu S, Wang J, Cai J, Xiao L, Yu L
and Wang Z: MiR-27a modulates MDR1/P-glycoprotein expression by
targeting HIPK2 in human ovarian cancer cells. Gynecol Oncol.
119:125–130. 2010. View Article : Google Scholar : PubMed/NCBI
|
31
|
Abuzeid WM, Jiang X, Shi G, Wang H,
Paulson D, Araki K, Jungreis D, Carney J, O’Malley BW Jr and Li D:
Molecular disruption of RAD50 sensitizes human tumor cells to
cisplatin-based chemotherapy. J Clin Invest. 119:1974–1985. 2009.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Lu X and Legerski RJ: The Prp19/Pso4 core
complex undergoes ubiquitylation and structural alterations in
response to DNA damage. Biochem Biophys Res Commun. 354:968–974.
2007. View Article : Google Scholar : PubMed/NCBI
|
33
|
Gonzalez-Suarez I, Redwood AB and Gonzalo
S: Loss of A-type lamins and genomic instability. Cell Cycle.
8:3860–3865. 2009. View Article : Google Scholar : PubMed/NCBI
|
34
|
Bortner JD Jr, Das A, Umstead TM, Freeman
WM, Somiari R, Aliaga C, Phelps DS and El-Bayoumy K:
Down-regulation of 14-3-3 isoforms and annexin A5 proteins in lung
adenocarcinoma induced by the tobacco-specific nitrosamine NNK in
the A/J mouse revealed by proteomic analysis. J Proteome Res.
8:4050–4061. 2009. View Article : Google Scholar : PubMed/NCBI
|
35
|
Connolly D, Abdesselam I, Verdier-Pinard P
and Montagna C: Septin roles in tumorigenesis. Biol Chem.
392:725–738. 2011. View Article : Google Scholar : PubMed/NCBI
|
36
|
Joseph J, Cruz-Sanchez FF and Carreras J:
Enolase activity and isoenzyme distribution in human brain regions
and tumors. J Neurochem. 66:2484–2490. 1996. View Article : Google Scholar : PubMed/NCBI
|
37
|
D’Costa J, Mansfield SG and Humeau LM:
Lentiviral vectors in clinical trials: current status. Curr Opin
Mol Ther. 11:554–564. 2009.
|